Skip to main content

Advertisement

Log in

Updated Review on the Clinical Use of Repetitive Transcranial Magnetic Stimulation in Psychiatric Disorders

  • Review
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

With the ability to modulate cortical activity, repetitive transcranial magnetic stimulation (rTMS) is becoming increasingly important in clinical applications for psychiatric disorders. Previous studies have demonstrated its promising efficacy in depression and schizophrenia, and emerging evidence has also been found in patients with anxiety disorder, obsessive–compulsive disorder, and substance or food craving. However, the overall literature features some conflicting results, varied quality of studies, and a lack of consensus on optimal rTMS parameters. Besides, the efficacy of rTMS in patients with medication-resistant symptoms has drawn most attention from clinicians. Here we review multi-site studies and double-blind randomized controlled trials (RCTs) in single sites, as well as meta-analyses of RCTs in the last three years, in order to update evidence on efficacy and the optimal protocol of rTMS in psychiatric disorders, especially for medication-resistant symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985, 1: 1106–1107.

    Article  CAS  PubMed  Google Scholar 

  2. Siebner HR, Tormos JM, Ceballos-Baumann AO, Auer C, Catala MD, Conrad B, et al. Low-frequency repetitive transcranial magnetic stimulation of the motor cortex in writer’s cramp. Neurology 1999, 52: 529–537.

    Article  CAS  PubMed  Google Scholar 

  3. Pascual-Leone A, Tarazona F, Keenan J, Tormos JM, Hamilton R, Catala MD. Transcranial magnetic stimulation and neuroplasticity. Neuropsychologia 1999, 37: 207–217.

    Article  CAS  PubMed  Google Scholar 

  4. Sommer M, Alfaro A, Rummel M, Speck S, Lang N, Tings T, et al. Half sine, monophasic and biphasic transcranial magnetic stimulation of the human motor cortex. Clin Neurophysiol 2006, 117: 838–844.

    Article  PubMed  Google Scholar 

  5. Siebner HR, Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res 2003, 148: 1–16.

    Article  PubMed  Google Scholar 

  6. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron 2005, 45: 201–206.

    Article  CAS  PubMed  Google Scholar 

  7. Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973, 232: 331–356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Malenka RC. Postsynaptic factors control the duration of synaptic enhancement in area CA1 of the hippocampus. Neuron 1991, 6: 53–60.

    Article  CAS  PubMed  Google Scholar 

  9. Janicak PG, O’Reardon JP, Sampson SM, Husain MM, Lisanby SH, Rado JT, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry 2008, 69: 222–232.

    Article  PubMed  Google Scholar 

  10. Zangen A, Roth Y, Voller B, Hallett M. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 2005, 116: 775–779.

    Article  PubMed  Google Scholar 

  11. Oberman L, Edwards D, Eldaief M, Pascual-Leone A. Safety of theta burst transcranial magnetic stimulation: a systematic review of the literature. J Clin Neurophysiol 2011, 28: 67–74.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009, 120: 2008–2039.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul 2016, 9: 336–346.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tringali S, Perrot X, Collet L, Moulin A. Repetitive transcranial magnetic stimulation: hearing safety considerations. Brain Stimul 2012, 5: 354–363.

    Article  PubMed  Google Scholar 

  15. Berlim MT, Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007, 52: 46–54.

    Article  PubMed  Google Scholar 

  16. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163: 1905–1917.

    Article  PubMed  Google Scholar 

  17. Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S, et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry 1999, 56: 315–320.

    Article  CAS  PubMed  Google Scholar 

  18. George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li XB, et al. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 2000, 48: 962–970.

    Article  CAS  PubMed  Google Scholar 

  19. Akhtar H, Bukhari F, Nazir M, Anwar MN, Shahzad A. Therapeutic efficacy of neurostimulation for depression: techniques, current modalities, and future challenges. Neurosci Bull 2016, 32: 115–126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Brunelin J, Jalenques I, Trojak B, Attal J, Szekely D, Gay A, et al. The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT. Brain Stimul 2014, 7: 855–863.

    Article  PubMed  Google Scholar 

  21. Jin Y, Phillips B. A pilot study of the use of EEG-based synchronized Transcranial Magnetic Stimulation (sTMS) for treatment of Major Depression. BMC Psychiatry 2014, 14: 13.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, et al. Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. Brain Stimul 2015, 8: 787–794.

    Article  PubMed  Google Scholar 

  23. Health Quality Ontario. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials. Ont Health Technol Assess Ser 2016, 16: 1–66.

    Google Scholar 

  24. Liu B, Zhang Y, Zhang L, Li L. Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study. BMC Psychiatry 2014, 14: 342.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Jiang J, Wang J, Li C. Potential mechanisms underlying the therapeutic effects of electroconvulsive therapy. Neurosci Bull 2017, 33: 339–347.

    Article  CAS  PubMed  Google Scholar 

  26. Ren J, Li H, Palaniyappan L, Liu H, Wang J, Li C, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2014, 51: 181–189.

    Article  PubMed  Google Scholar 

  27. Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2014, 44: 225–239.

    Article  CAS  PubMed  Google Scholar 

  28. Chen JJ, Liu Z, Zhu D, Li Q, Zhang H, Huang H, et al. Bilateral vs. unilateral repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomized controlled trials. Psychiatry Res 2014, 219: 51–57.

    Article  PubMed  Google Scholar 

  29. Zhang YQ, Zhu D, Zhou XY, Liu YY, Qin B, Ren GP, et al. Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials. Braz J Med Biol Res 2015, 48: 198–206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kedzior KK, Reitz SK, Azorina V, Loo C. Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials. Depress Anxiety 2015, 32: 193–203.

    Article  PubMed  Google Scholar 

  31. Connolly KR, Helmer A, Cristancho MA, Cristancho P, O’Reardon JP. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J Clin Psychiatry 2012, 73: e567–e573.

    Article  PubMed  Google Scholar 

  32. Chiara RapinesiO’Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005, 66: 1524–1528.

    Article  Google Scholar 

  33. Fitzgerald PB, Grace N, Hoy KE, Bailey M, Daskalakis ZJ. An open label trial of clustered maintenance rTMS for patients with refractory depression. Brain Stimul 2013, 6: 292–297.

    Article  PubMed  Google Scholar 

  34. Richieri R, Guedj E, Michel P, Loundou A, Auquier P, Lancon C, et al. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J Affect Disord 2013, 151: 129–135.

    Article  PubMed  Google Scholar 

  35. Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study. World J Biol Psychiatry 2014, 15: 298–306.

    Article  PubMed  Google Scholar 

  36. Haesebaert F, Moirand R, Schott-Pethelaz AM, Brunelin J, Poulet E. Usefulness of repetitive transcranial magnetic stimulation as a maintenance treatment in patients with major depression. World J Biol Psychiatry 2016, 1–5.

  37. Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry 2015, 14: 64–73.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, et al. Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? A prospective, 12-month multisite randomized pilot study. Brain Stimul 2016, 9: 251–257.

    Article  PubMed  Google Scholar 

  39. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995, 378: 176–179.

    Article  CAS  PubMed  Google Scholar 

  40. Hoffman RE, Boutros NN, Berman RM, Roessler E, Belger A, Krystal JH, et al. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”. Biol Psychiatry 1999, 46: 130–132.

    Article  CAS  PubMed  Google Scholar 

  41. Dougall N, Maayan N, Soares-Weiser K, McDermott LM, McIntosh A. Transcranial magnetic stimulation for schizophrenia. Schizophr Bull 2015, 41: 1220–1222.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Koops S, van Dellen E, Schutte MJ, Nieuwdorp W, Neggers SF, Sommer IE. Theta burst transcranial magnetic stimulation for auditory verbal hallucinations: negative findings from a double-blind-randomized trial. Schizophr Bull 2016, 42: 250–257.

    PubMed  Google Scholar 

  43. Slotema CW, Blom JD, van Lutterveld R, Hoek HW, Sommer IE. Review of the efficacy of transcranial magnetic stimulation for auditory verbal hallucinations. Biol Psychiatry 2014, 76: 101–110.

    Article  PubMed  Google Scholar 

  44. Dlabac-de Lange JJ, Bais L, van Es FD, Visser BG, Reinink E, Bakker B, et al. Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial. Psychol Med 2015, 45: 1263–1275.

    Article  CAS  PubMed  Google Scholar 

  45. Quan WX, Zhu XL, Qiao H, Zhang WF, Tan SP, Zhou DF, et al. The effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia and the follow-up study. Neurosci Lett 2015, 584: 197–201.

    Article  CAS  PubMed  Google Scholar 

  46. Wobrock T, Guse B, Cordes J, Wolwer W, Winterer G, Gaebel W, et al. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biol Psychiatry 2015, 77: 979–988.

    Article  PubMed  Google Scholar 

  47. Dlabac-de Lange JJ, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry 2010, 71: 411–418.

    Article  PubMed  Google Scholar 

  48. Shi C, Yu X, Cheung EF, Shum DH, Chan RC. Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis. Psychiatry Res 2014, 215: 505–513.

    Article  PubMed  Google Scholar 

  49. Hasan A, Guse B, Cordes J, Wolwer W, Winterer G, Gaebel W, et al. Cognitive effects of high-frequency rTMS in schizophrenia patients with predominant negative symptoms: results from a multicenter randomized sham-controlled trial. Schizophr Bull 2016, 42: 608–618.

    Article  PubMed  Google Scholar 

  50. Berlim MT, Van Den Eynde F. Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: an exploratory meta-analysis of randomized, double-blind and sham-controlled trials. Can J Psychiatry 2014, 59: 487–496.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Wahbeh H, Senders A, Neuendorf R, Cayton J. Complementary and alternative medicine for posttraumatic stress disorder symptoms: a systematic review. J Evid Based Complementary Altern Med 2014, 19: 161–175.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Trevizol AP, Barros MD, Silva PO, Osuch E, Cordeiro Q, Shiozawa P. Transcranial magnetic stimulation for posttraumatic stress disorder: an updated systematic review and meta-analysis. Trends Psychiatry Psychother 2016, 38: 50–55.

    Article  PubMed  Google Scholar 

  53. Li H, Wang J, Li C, Xiao Z. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults. Cochrane Database Syst Rev 2014, CD009083.

  54. Modirrousta M, Shams E, Katz C, Mansouri B, Moussavi Z, Sareen J, et al. The efficacy of deep repetitive transcranial magnetic stimulation over the medial prefrontal cortex in obsessive compulsive disorder: results from an open-label study. Depress Anxiety 2015, 32: 445–450.

    Article  PubMed  Google Scholar 

  55. Greenberg BD, Ziemann U, Harmon A, Murphy DL, Wassermann EM. Decreased neuronal inhibition in cerebral cortex in obsessive–compulsive disorder on transcranial magnetic stimulation. Lancet 1998, 352: 881–882.

    Article  CAS  PubMed  Google Scholar 

  56. Greenberg BD, Ziemann U, Cora-Locatelli G, Harmon A, Murphy DL, Keel JC, et al. Altered cortical excitability in obsessive–compulsive disorder. Neurology 2000, 54: 142–147.

    Article  CAS  PubMed  Google Scholar 

  57. Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive–compulsive disorder (OCD) and Tourette’s syndrome (TS). Int J Neuropsychopharmacol 2006, 9: 95–100.

    Article  PubMed  Google Scholar 

  58. Hawken ER, Dilkov D, Kaludiev E, Simek S, Zhang F, Milev R. Transcranial magnetic stimulation of the supplementary motor area in the treatment of obsessive–compulsive disorder: a multi-site study. Int J Mol Sci 2016, 17: 420.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Elbeh KA, Elserogy YM, Khalifa HE, Ahmed MA, Hafez MH, Khedr EM. Repetitive transcranial magnetic stimulation in the treatment of obsessive–compulsive disorders: Double blind randomized clinical trial. Psychiatry Res 2016, 238: 264–269.

    Article  PubMed  Google Scholar 

  60. Nauczyciel C, Le Jeune F, Naudet F, Douabin S, Esquevin A, Verin M, et al. Repetitive transcranial magnetic stimulation over the orbitofrontal cortex for obsessive–compulsive disorder: a double-blind, crossover study. Transl Psychiatry 2014, 4: e436.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Ma X, Huang Y, Liao L, Jin Y. A randomized double-blinded sham-controlled trial of alpha electroencephalogram-guided transcranial magnetic stimulation for obsessive–compulsive disorder. Chin Med J (Engl) 2014, 127: 601–606.

    Google Scholar 

  62. Dinur-Klein L, Dannon P, Hadar A, Rosenberg O, Roth Y, Kotler M, et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biol Psychiatry 2014, 76: 742–749.

    Article  PubMed  Google Scholar 

  63. Gay A, Jaussent I, Sigaud T, Billard S, Attal J, Seneque M, et al. A lack of clinical effect of high-frequency rTMS to dorsolateral prefrontal cortex on bulimic symptoms: a randomised, double-blind trial. Eur Eat Disord Rev 2016, 24: 474–481.

    Article  PubMed  Google Scholar 

  64. Bolloni C, Panella R, Pedetti M, Frascella AG, Gambelunghe C, Piccoli T, et al. Bilateral transcranial magnetic stimulation of the prefrontal cortex reduces cocaine intake: a pilot study. Front Psychiatry 2016, 7: 133.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Terraneo A, Leggio L, Saladini M, Ermani M, Bonci A, Gallimberti L. Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study. Eur Neuropsychopharmacol 2016, 26: 37–44.

    Article  CAS  PubMed  Google Scholar 

  66. Enokibara M, Trevizol A, Shiozawa P, Cordeiro Q. Establishing an effective TMS protocol for craving in substance addiction: Is it possible? Am J Addict 2016, 25: 28–30.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This review was supported by grants from the National Natural Science Foundation of China (81501152 and 81671332), the National Key Basic Research and Development Program, Ministry of Science and Technology, China (2016YFC1306800, 2016YFC1306803), the Brain Project of Shanghai Jiaotong University, School of Medicine, China (2015NKX001, 15ZH2015, and W35XT), and Shanghai Hospital Development Center, China (SHDC12014111).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jijun Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, Q., Li, C. & Wang, J. Updated Review on the Clinical Use of Repetitive Transcranial Magnetic Stimulation in Psychiatric Disorders. Neurosci. Bull. 33, 747–756 (2017). https://doi.org/10.1007/s12264-017-0185-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-017-0185-3

Keywords

Navigation